O	0	8	Phenolic	Phenolic	JJ	B-NP
O	9	17	fraction	fraction	NN	I-NP
O	18	20	of	of	IN	B-PP
O	21	28	tobacco	tobacco	NN	B-NP
O	29	34	smoke	smoke	NN	I-NP
O	35	45	condensate	condensate	NN	I-NP
O	46	57	potentiates	potentiate	VBZ	B-VP
O	58	63	benzo	benzo	NN	B-NP
O	63	64	[	[	(	O
O	64	65	a	a	DT	B-NP
O	65	66	]	]	)	I-NP
O	66	73	pyerene	pyerene	NN	I-NP
O	74	78	diol	diol	NN	I-NP
O	79	86	epoxide	epoxide	NN	I-NP
O	86	87	-	-	HYPH	B-NP
O	87	94	induced	induce	VBN	I-NP
B-Cell	95	99	cell	cell	NN	I-NP
O	100	114	transformation	transformation	NN	I-NP
O	114	115	:	:	:	O
O	116	120	role	role	NN	B-NP
O	121	123	of	of	IN	B-PP
O	124	131	protein	protein	NN	B-NP
O	132	138	kinase	kinase	NN	I-NP
O	139	140	C	C	NN	I-NP
O	140	141	.	.	.	O

O	143	145	In	In	IN	B-PP
O	146	150	this	this	DT	B-NP
O	151	156	study	study	NN	I-NP
O	157	159	we	we	PRP	B-NP
O	160	169	separated	separate	VBD	B-VP
O	170	176	weakly	weakly	RB	B-NP
O	177	183	acidic	acidic	JJ	I-NP
O	184	192	phenolic	phenolic	JJ	I-NP
O	193	203	components	component	NNS	I-NP
O	204	208	from	from	IN	B-PP
O	209	214	other	other	JJ	B-NP
O	215	222	neutral	neutral	JJ	I-NP
O	222	223	,	,	,	I-NP
O	224	230	acidic	acidic	JJ	I-NP
O	231	234	and	and	CC	I-NP
O	235	240	basic	basic	JJ	I-NP
O	241	251	components	component	NNS	I-NP
O	252	254	of	of	IN	B-PP
O	255	262	tobacco	tobacco	NN	B-NP
O	263	268	smoke	smoke	NN	I-NP
O	269	279	condensate	condensate	NN	I-NP
O	280	281	(	(	(	O
O	281	284	TSC	TSC	NN	B-NP
O	284	285	)	)	)	O
O	286	289	and	and	CC	O
O	290	298	observed	observe	VBN	B-VP
O	299	303	that	that	IN	B-SBAR
O	304	312	phenolic	phenolic	JJ	B-NP
O	313	321	fraction	fraction	NN	I-NP
O	322	324	of	of	IN	B-PP
O	325	328	TSC	TSC	NN	B-NP
O	329	342	significantly	significantly	RB	B-ADVP
O	343	352	increased	increase	VBD	B-VP
O	353	356	the	the	DT	B-NP
O	357	363	number	number	NN	I-NP
O	364	366	of	of	IN	B-PP
B-Cell	367	375	colonies	colony	NNS	B-NP
O	376	378	of	of	IN	B-PP
O	379	388	promotion	promotion	NN	B-NP
O	388	389	-	-	HYPH	B-NP
O	389	398	sensitive	sensitive	JJ	I-NP
B-Cell	399	402	JB6	JB6	NN	I-NP
I-Cell	403	407	Cl41	Cl41	NN	I-NP
I-Cell	408	413	cells	cell	NNS	I-NP
O	414	418	that	that	WDT	B-NP
O	419	425	showed	show	VBD	B-VP
O	426	435	anchorage	anchorage	NN	B-NP
O	435	436	-	-	HYPH	B-NP
O	436	447	independent	independent	JJ	I-NP
O	448	454	growth	growth	NN	I-NP
O	455	457	on	on	IN	B-PP
O	458	462	soft	soft	JJ	B-NP
O	463	467	agar	agar	NN	I-NP
O	468	470	in	in	IN	B-PP
O	471	479	response	response	NN	I-PP
O	480	482	to	to	TO	I-PP
O	483	487	BPDE	BPDE	NN	B-NP
O	488	489	(	(	(	O
O	489	491	an	an	DT	B-NP
O	492	500	ultimate	ultimate	JJ	I-NP
O	501	511	carcinogen	carcinogen	NN	I-NP
O	512	520	produced	produce	VBN	B-VP
O	521	523	by	by	IN	B-PP
O	524	533	metabolic	metabolic	JJ	B-NP
O	534	544	activation	activation	NN	I-NP
O	545	547	of	of	IN	B-PP
O	548	551	the	the	DT	B-NP
O	552	555	PAH	PAH	NN	I-NP
O	556	561	benzo	benzo	NN	I-NP
O	561	562	[	[	(	O
O	562	563	a	a	DT	O
O	563	564	]	]	)	O
O	564	570	pyrene	pyrene	NN	B-NP
O	570	571	)	)	)	O
O	571	572	.	.	.	O

O	573	582	Anchorage	Anchorage	NN	B-NP
O	582	583	-	-	HYPH	I-NP
O	583	594	independent	independent	JJ	I-NP
B-Cell	595	599	cell	cell	NN	I-NP
O	600	606	growth	growth	NN	I-NP
O	607	609	is	be	VBZ	B-VP
O	610	620	indicative	indicative	JJ	B-ADJP
O	621	623	of	of	IN	B-PP
B-Cell	624	628	cell	cell	NN	B-NP
O	629	643	transformation	transformation	NN	I-NP
O	644	653	resulting	result	VBG	B-VP
O	654	656	in	in	IN	B-PP
O	657	668	acquisition	acquisition	NN	B-NP
O	669	671	of	of	IN	B-PP
O	672	683	tumorigenic	tumorigenic	JJ	B-NP
O	684	693	potential	potential	NN	I-NP
O	693	694	.	.	.	O

O	695	697	In	In	IN	B-SBAR
O	698	703	order	order	NN	O
O	704	706	to	to	TO	B-VP
O	707	717	understand	understand	VB	I-VP
O	718	721	the	the	DT	B-NP
O	722	732	underlying	underlie	VBG	I-NP
O	733	742	mechanism	mechanism	NN	I-NP
O	743	745	by	by	IN	B-PP
O	746	751	which	which	WDT	B-NP
O	752	755	TSC	TSC	NN	B-NP
O	756	764	phenolic	phenolic	JJ	I-NP
O	765	773	fraction	fraction	NN	I-NP
O	774	785	potentiates	potentiate	VBZ	B-VP
O	786	790	BPDE	BPDE	NN	B-NP
O	790	791	-	-	HYPH	B-NP
O	791	798	induced	induce	VBN	I-NP
O	799	813	tumorigenicity	tumorigenicity	NN	I-NP
O	813	814	,	,	,	O
O	815	817	we	we	PRP	B-NP
O	818	826	examined	examine	VBD	B-VP
O	827	830	its	its	PRP$	B-NP
O	831	837	effect	effect	NN	I-NP
O	838	840	on	on	IN	B-PP
O	841	844	the	the	DT	B-NP
O	845	855	activation	activation	NN	I-NP
O	856	858	of	of	IN	B-PP
O	859	862	two	two	CD	B-NP
O	863	876	transcription	transcription	NN	I-NP
O	877	884	factors	factor	NNS	I-NP
O	885	887	AP	AP	NN	B-NP
O	887	888	-	-	HYPH	B-NP
O	888	889	1	1	CD	I-NP
O	890	893	and	and	CC	I-NP
O	894	896	NF	NF	NN	I-NP
O	896	897	-	-	HYPH	I-NP
O	897	903	kappaB	kappaB	NN	I-NP
O	904	909	which	which	WDT	B-NP
O	910	913	are	be	VBP	B-VP
O	914	919	known	know	VBN	I-VP
O	920	922	to	to	TO	I-VP
O	923	925	be	be	VB	I-VP
O	926	936	influenced	influence	VBN	I-VP
O	937	939	by	by	IN	B-PP
O	940	951	established	establish	VBN	B-NP
B-Cancer	952	957	tumor	tumor	NN	I-NP
O	958	966	promoter	promoter	NN	I-NP
O	967	970	TPA	TPA	NN	I-NP
O	970	971	.	.	.	O

O	972	976	BPDE	BPDE	NN	B-NP
O	977	986	treatment	treatment	NN	I-NP
O	987	993	caused	cause	VBD	B-VP
O	994	1003	induction	induction	NN	B-NP
O	1004	1006	of	of	IN	B-PP
O	1007	1011	both	both	CC	O
O	1012	1014	AP	AP	NN	B-NP
O	1014	1015	-	-	HYPH	B-NP
O	1015	1016	1	1	CD	I-NP
O	1017	1020	and	and	CC	I-NP
O	1021	1023	NF	NF	NN	I-NP
O	1023	1024	-	-	HYPH	I-NP
O	1024	1030	kappaB	kappaB	NN	I-NP
O	1031	1039	activity	activity	NN	I-NP
O	1040	1042	as	as	IN	B-SBAR
O	1043	1053	determined	determine	VBN	B-VP
O	1054	1056	by	by	IN	B-PP
O	1057	1067	luciferase	luciferase	NN	B-NP
O	1068	1076	reporter	reporter	NN	I-NP
O	1077	1082	assay	assay	NN	I-NP
O	1083	1086	and	and	CC	O
O	1087	1091	only	only	RB	B-NP
O	1092	1094	NF	NF	NN	I-NP
O	1094	1095	-	-	HYPH	I-NP
O	1095	1101	kappaB	kappaB	NN	I-NP
O	1102	1111	induction	induction	NN	I-NP
O	1112	1114	in	in	IN	B-PP
O	1115	1123	response	response	NN	I-PP
O	1124	1126	to	to	TO	I-PP
O	1127	1131	BPDE	BPDE	NN	B-NP
O	1132	1135	was	be	VBD	B-VP
O	1136	1149	significantly	significantly	RB	I-VP
O	1150	1160	attenuated	attenuate	VBN	I-VP
O	1161	1163	by	by	IN	B-PP
O	1164	1167	TSC	TSC	NN	B-NP
O	1168	1176	phenolic	phenolic	JJ	I-NP
O	1177	1185	fraction	fraction	NN	I-NP
O	1186	1193	whereas	whereas	IN	B-PP
O	1194	1196	AP	AP	NN	B-NP
O	1196	1197	-	-	HYPH	B-NP
O	1197	1198	1	1	CD	I-NP
O	1199	1208	induction	induction	NN	I-NP
O	1209	1216	remains	remain	VBZ	B-VP
O	1217	1226	unaltered	unaltered	JJ	B-ADJP
O	1226	1227	.	.	.	O

O	1228	1239	Attenuation	Attenuation	NN	B-NP
O	1240	1242	of	of	IN	B-PP
O	1243	1245	NF	NF	NN	B-NP
O	1245	1246	-	-	HYPH	B-NP
O	1246	1252	kappaB	kappaB	NN	I-NP
O	1253	1263	activation	activation	NN	I-NP
O	1264	1266	by	by	IN	B-PP
O	1267	1270	TSC	TSC	NN	B-NP
O	1271	1279	phenolic	phenolic	JJ	I-NP
O	1280	1288	fraction	fraction	NN	I-NP
O	1289	1292	was	be	VBD	B-VP
O	1293	1303	associated	associate	VBN	I-VP
O	1304	1308	with	with	IN	B-PP
O	1309	1320	significant	significant	JJ	B-NP
O	1321	1329	decrease	decrease	NN	I-NP
O	1330	1332	of	of	IN	B-PP
B-Immaterial_anatomical_entity	1333	1346	intracellular	intracellular	JJ	B-NP
O	1347	1350	PKC	PKC	NN	I-NP
O	1351	1360	substrate	substrate	NN	I-NP
O	1361	1376	phosphorylation	phosphorylation	NN	I-NP
O	1377	1379	in	in	IN	B-PP
O	1380	1384	BPDE	BPDE	NN	B-NP
O	1385	1392	treated	treat	VBN	B-VP
B-Cell	1393	1398	cells	cell	NNS	B-NP
O	1398	1399	.	.	.	O

O	1400	1403	Non	Non	AFX	B-NP
O	1403	1404	-	-	HYPH	I-NP
O	1404	1412	specific	specific	JJ	I-NP
O	1413	1416	PKC	PKC	NN	I-NP
O	1417	1427	inhibitors	inhibitor	NNS	I-NP
O	1428	1441	staurosporine	staurosporine	NN	I-NP
O	1442	1445	and	and	CC	I-NP
O	1446	1465	bisindolylmaleimide	bisindolylmaleimide	NN	I-NP
O	1466	1468	II	II	CD	I-NP
O	1469	1471	as	as	RB	B-CONJP
O	1472	1476	well	well	RB	I-CONJP
O	1477	1479	as	as	IN	I-CONJP
O	1480	1490	inhibitors	inhibitor	NNS	B-NP
O	1491	1499	specific	specific	JJ	B-ADJP
O	1500	1502	to	to	TO	B-PP
O	1503	1515	conventional	conventional	JJ	B-NP
O	1516	1520	PKCs	PKC	NNS	I-NP
O	1521	1522	(	(	(	O
O	1522	1528	Go6976	Go6976	NN	B-NP
O	1528	1529	)	)	)	O
O	1530	1533	and	and	CC	O
O	1534	1537	PKC	PKC	NN	B-NP
O	1537	1538	-	-	HYPH	O
O	1538	1543	delta	delta	SYM	B-NP
O	1544	1545	(	(	(	O
O	1545	1554	rottlerin	rottlerin	NN	B-NP
O	1554	1555	)	)	)	O
O	1556	1566	attenuated	attenuate	VBD	B-VP
O	1567	1569	NF	NF	NN	B-NP
O	1569	1570	-	-	HYPH	B-NP
O	1570	1576	kappaB	kappaB	NN	I-NP
O	1577	1587	activation	activation	NN	I-NP
O	1588	1590	in	in	IN	B-PP
O	1591	1595	BPDE	BPDE	NN	B-NP
O	1596	1603	treated	treat	VBN	I-NP
B-Cell	1604	1609	cells	cell	NNS	I-NP
O	1610	1612	to	to	TO	B-PP
O	1613	1614	a	a	DT	B-NP
O	1615	1622	varying	vary	VBG	I-NP
O	1623	1629	degree	degree	NN	I-NP
O	1630	1640	indicating	indicate	VBG	B-VP
O	1641	1642	a	a	DT	B-NP
O	1643	1651	possible	possible	JJ	I-NP
O	1652	1656	link	link	NN	I-NP
O	1657	1664	between	between	IN	B-PP
O	1665	1668	PKC	PKC	NN	B-NP
O	1669	1673	down	down	RB	B-ADVP
O	1673	1674	-	-	HYPH	B-NP
O	1674	1684	regulation	regulation	NN	I-NP
O	1685	1688	and	and	CC	O
O	1689	1692	the	the	DT	B-NP
O	1693	1704	attenuation	attenuation	NN	I-NP
O	1705	1707	of	of	IN	B-PP
O	1708	1710	NF	NF	NN	B-NP
O	1710	1711	-	-	HYPH	B-NP
O	1711	1717	kappaB	kappaB	NN	I-NP
O	1718	1726	activity	activity	NN	I-NP
O	1727	1729	by	by	IN	B-PP
O	1730	1733	TSC	TSC	NN	B-NP
O	1734	1742	phenolic	phenolic	JJ	I-NP
O	1743	1751	fraction	fraction	NN	I-NP
O	1751	1752	.	.	.	O

O	1753	1762	Treatment	Treatment	NN	B-NP
O	1763	1765	of	of	IN	B-PP
B-Cell	1766	1771	cells	cell	NNS	B-NP
O	1772	1776	with	with	IN	B-PP
O	1777	1780	PKC	PKC	NN	B-NP
O	1781	1791	inhibitors	inhibitor	NNS	I-NP
O	1792	1796	also	also	RB	B-ADVP
O	1797	1808	potentiated	potentiate	VBD	B-VP
O	1809	1818	anchorage	anchorage	NN	B-NP
O	1818	1819	-	-	HYPH	B-NP
O	1819	1830	independent	independent	JJ	I-NP
O	1831	1837	growth	growth	NN	I-NP
O	1838	1840	of	of	IN	B-PP
O	1841	1845	BPDE	BPDE	NN	B-NP
O	1846	1853	treated	treat	VBN	B-VP
B-Cell	1854	1859	cells	cell	NNS	B-NP
O	1860	1862	on	on	IN	B-PP
O	1863	1867	soft	soft	JJ	B-NP
O	1868	1872	agar	agar	NN	I-NP
O	1872	1873	.	.	.	O

O	1874	1877	Our	Our	PRP$	B-NP
O	1878	1882	data	datum	NNS	I-NP
O	1883	1890	suggest	suggest	VBP	B-VP
O	1891	1892	a	a	DT	B-NP
O	1893	1901	possible	possible	JJ	I-NP
O	1902	1906	role	role	NN	I-NP
O	1907	1909	of	of	IN	B-PP
O	1910	1913	PKC	PKC	NN	B-NP
O	1914	1918	down	down	RB	B-ADVP
O	1918	1919	-	-	HYPH	B-NP
O	1919	1929	regulation	regulation	NN	I-NP
O	1930	1932	in	in	IN	B-PP
O	1933	1945	potentiation	potentiation	NN	B-NP
O	1946	1948	of	of	IN	B-PP
O	1949	1953	BPDE	BPDE	NN	B-NP
O	1953	1954	-	-	HYPH	B-NP
O	1954	1961	induced	induce	VBN	I-NP
O	1962	1976	tumorogenicity	tumorogenicity	NN	I-NP
O	1977	1979	by	by	IN	B-PP
O	1980	1983	TSC	TSC	NN	B-NP
O	1984	1992	phenolic	phenolic	JJ	I-NP
O	1993	2001	fraction	fraction	NN	I-NP
O	2001	2002	.	.	.	O

